Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.4B | 20.3B | 19.7B | 18.1B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 70M | 69.9M | 69.9M | 69.6M |
Other income expense | — | — | — | — |
Pretax income | 3.2B | 3.0B | 2.9B | 1.9B |
Tax provision | 669M | 611.4M | 611.4M | 401.7M |
Net income | 2.6B | 2.4B | 2.3B | 1.5B |
Basic EPS | 4.4 | — | 4.0 | 2.5 |
Diluted EPS | 4.4 | — | 4.0 | 2.5 |
Basic average shares | 586M | — | 585.6M | 585.4M |
Diluted average shares | 587.7M | — | 587.6M | 587.4M |
EBITDA | — | — | — | — |
Net income from continuing op. | 2.6B | 2.4B | 2.3B | 1.5B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |